GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Control Bionics CBL.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.05

+2.04%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

A$7.0m

FY2018FY2025

Net income

−A$6.1m

FY2018FY2025

Free cash flow

−A$4.7m

FY2018FY2025

Shareholders' equity

A$5.5m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueA$7.0mA$6.0mA$5.9mA$4.7mA$4.1mA$3.3mA$901,400A$892,400
Gross profitA$5.0mA$4.6mA$4.0mA$2.7mA$2.7mA$2.6mA$556,100A$818,400
Research and developmentA$1.1mA$1.7mA$231,000A$328,900A$166,200A$68,300A$361,200A$79,000
Operating income−A$5.9m−A$5.9m−A$5.2m−A$6.1m−A$3.1m−A$999,800−A$1.9m−A$971,300
Net income−A$6.1m−A$5.9m−A$5.6m−A$6.1m−A$3.6m−A$1.0m−A$1.9m−A$972,500
Diluted earnings per share-0.02-0.04-0.06-0.06-0.05-0.01-0.02-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsA$8.2mA$9.0mA$8.7mA$13.4mA$18.4mA$6.3mA$5.4mA$6.3m
Cash and short-term investmentsA$594,700A$980,800A$935,500A$5.2mA$12.3mA$1.4mA$798,900A$1.8m
Total liabilitiesA$2.7mA$2.8mA$1.5mA$1.5mA$1.2mA$622,400A$375,800A$215,900
DebtA$435,400A$961,800A$128,500A$284,800A$14,900A$282,400——
Shareholders' equityA$5.5mA$6.3mA$7.1mA$11.9mA$17.2mA$5.7mA$5.1mA$6.1m
Shares outstanding270m163m102m97m70m83m83m83m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−A$4.3m−A$4.9m−A$4.5m−A$6.9m−A$4.0m−A$864,100−A$1.9m−A$970,800
Capital spending−A$442,000−A$473,100−A$457,500−A$147,700−A$53,400−A$301,900−A$35,700−A$14,300
Free cash flow−A$4.7m−A$5.4m−A$5.0m−A$7.0m−A$4.0m−A$1.2m−A$2.0m−A$985,100

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueA$3.8mA$3.3mA$2.7mA$3.4mA$3.1mA$2.8mA$2.4mA$2.4m
Gross profitA$2.8mA$2.2mA$2.0mA$2.6mA$2.4mA$1.6mA$1.4mA$1.4m
Operating income−A$2.8m−A$3.1m−A$3.7m−A$2.2m−A$2.2m−A$3.0m−A$3.0m−A$3.1m
Net income−A$2.9m−A$3.2m−A$3.7m−A$2.2m−A$2.6m−A$3.0m−A$3.0m−A$3.1m
Diluted earnings per share-0.01-0.01-0.02-0.02-0.03-0.03-0.03-0.04
Total assetsA$8.2mA$8.8mA$9.0mA$8.9mA$8.7mA$11.0mA$13.4mA$16.5m
Cash and short-term investmentsA$594,700A$972,200A$980,800A$1.3mA$935,500A$3.0mA$5.2mA$8.5m
DebtA$228,500A$238,300A$853,300A$46,500A$62,700A$79,500A$172,800A$398,700
Shareholders' equityA$5.5mA$6.5mA$6.3mA$7.7mA$7.1mA$9.7mA$11.9mA$14.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.3%16.4%—
Operating income-1.2%42.7%—
Net income0.0%43.5%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin73.3%68.8%69.3%—
Operating margin-90.2%-97.7%-87.8%—
Net margin-92.0%-100.2%-91.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-2.7-1.6-0.8-2.4-7.5-70.3
Price to sales2.31.60.83.06.521.4

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.